All In Biotech

Drug Trial Radar · NCT04679870

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis

An Open-label, Phase IIa Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 (a LOXL2 Inhibitor) in Participants With Myelofibrosis (MF)

Last checked: Nov 19, 2026Latest source record: Apr 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

21

Planned (sponsor's estimate)

Start

Jun 9, 2021

Primary completion

Dec 31, 2023

Study completion Jun 30, 2026

Sponsor

Lead sponsor
Galecto Biotech ABIndustry
Sponsor type
Industry
Collaborators
OPIS s.r.l
First posted
Dec 22, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is an open label, phase IIa trial in subjects with Myelofibrosis

Conditions

  • Myelofibrosis

Interventions

  • GB2064Drug

    GB2064 (formerly PAT-1251) is a high-affinity, selective, mechanism-based, small molecule inhibitor of LOXL2, administered twice a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of GB2064: AETime frame: 9 Months

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • MD Andersson Cancer Hospital

    Houston, Texas

  • Woden Dermatology

    Canberra, Australia

  • Heinrich-Heine-University Dusseldorf

    Düsseldorf, Germany

  • Universitätsklinikum Heidelberg

    Heidelberg, Germany

  • Universität Leipzig

    Leipzig, Germany

  • Klinikum rechts der Isar der Technischen Universitaet Munchen

    München, Germany

  • University of Bologna Sant Orsola Malpighi

    Bologna, Italy

  • Azienda Ospedaliero-Universitaria Careggi

    Florence, Italy

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, Italy

  • Azienda Ospedaliero-Universitaria San Luigi Gonzaga di Orbassano

    Orbassano, Italy

  • Azienda Socio-Sanitaria Territoriale dei Sette Laghi

    Varese, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.